<p>(<b>A</b>) <i>T</i>. <i>brucei</i> wild type (WT), <i>msh2</i>+/-, <i>msh2</i>-/-, <i>mlh1</i>+/- and <i>mlh1</i>-/- procyclic form cells were grown in culture medium with 0 μM, 10 μM or 20 μM H<sub>2</sub>O<sub>2</sub>. Cell density was measured after 48 hours and plotted as the percentage survival of the H<sub>2</sub>O<sub>2</sub> treated cells relative to untreated. (<b>B</b>) <i>T</i>. <i>cruzi</i> epimastigote WT, <i>msh2</i>+/- and <i>msh2</i>-/- cells were incubated with or without 75 μM H<sub>2</sub>O<sub>2</sub> for 20 minutes in PBS 1x and then allowed to grow in LIT medium for 48 hours, after which cell viability was determined and plotted as percentage survival of the treated cells relative to untreated. Vertical lines show s...
<p>(A) Under conditions with no genotoxic treatment, the <i>MEC1</i> P2186A/A2351S double mutant sho...
<p>Mutants of known pathways involved in antioxidant defence and oxidative stress responses were ana...
Data is reported as a ratio of average OD (tx) to average starting OD (t0) in each survival curve (n...
<p>(<b>A</b>) Procyclic form (PCF) <i>T</i>. <i>brucei</i> (Tb) wild type (WT), <i>Tbmsh2</i>+/-, <i...
<p>(<b>A</b>) <i>T</i>. <i>brucei</i> wild type (WT) and procyclic form mutants (<i>Tbmsh2</i>+/-, <...
<p>(A) Growth assays of serial dilutions of W303-1A (wild type), MML1081 (<i>Δcth1 Δcth2</i>) and MM...
<p>(A) The steady-state level of the indicated wild type (WT) or MSH2 mutants expressed in U2OS cell...
<p>(A) The MSH2 variants were analyzed for interaction with MSH6. Endogenous MSH6 was immunoprecipit...
<p>(A) Twenty-four hours after exposure to diverse concentrations of H<sub>2</sub>O<sub>2</sub> for ...
<p>A), B) and C) Exponentially growing cells (O.D. <sub>620 nm</sub> = 1) of the indicated strains w...
<p>A-C. Trypan blue exclusion assays. The G93A mutation was the most susceptible to oxidative stress...
<p>Seven mutants <i>CG9650<sup>BG01024</sup></i>, <i>Eip75B<sup>BG02737</sup></i>, <i>ena<sup>BG0218...
<p>FITC-avidin was used to estimate 8-oxoG levels based on the fluorescence intensity in the nuclear...
<p><b>(</b>A) The H<sub>2</sub>O<sub>2</sub> production is altered in the <i>comE</i> and <i>stkP</i...
<p><b>(A)</b> Schematic structure of MDHDC (4-methyl-1,4-dihydropyridine-3,5-dicarbaldehyde), the mo...
<p>(A) Under conditions with no genotoxic treatment, the <i>MEC1</i> P2186A/A2351S double mutant sho...
<p>Mutants of known pathways involved in antioxidant defence and oxidative stress responses were ana...
Data is reported as a ratio of average OD (tx) to average starting OD (t0) in each survival curve (n...
<p>(<b>A</b>) Procyclic form (PCF) <i>T</i>. <i>brucei</i> (Tb) wild type (WT), <i>Tbmsh2</i>+/-, <i...
<p>(<b>A</b>) <i>T</i>. <i>brucei</i> wild type (WT) and procyclic form mutants (<i>Tbmsh2</i>+/-, <...
<p>(A) Growth assays of serial dilutions of W303-1A (wild type), MML1081 (<i>Δcth1 Δcth2</i>) and MM...
<p>(A) The steady-state level of the indicated wild type (WT) or MSH2 mutants expressed in U2OS cell...
<p>(A) The MSH2 variants were analyzed for interaction with MSH6. Endogenous MSH6 was immunoprecipit...
<p>(A) Twenty-four hours after exposure to diverse concentrations of H<sub>2</sub>O<sub>2</sub> for ...
<p>A), B) and C) Exponentially growing cells (O.D. <sub>620 nm</sub> = 1) of the indicated strains w...
<p>A-C. Trypan blue exclusion assays. The G93A mutation was the most susceptible to oxidative stress...
<p>Seven mutants <i>CG9650<sup>BG01024</sup></i>, <i>Eip75B<sup>BG02737</sup></i>, <i>ena<sup>BG0218...
<p>FITC-avidin was used to estimate 8-oxoG levels based on the fluorescence intensity in the nuclear...
<p><b>(</b>A) The H<sub>2</sub>O<sub>2</sub> production is altered in the <i>comE</i> and <i>stkP</i...
<p><b>(A)</b> Schematic structure of MDHDC (4-methyl-1,4-dihydropyridine-3,5-dicarbaldehyde), the mo...
<p>(A) Under conditions with no genotoxic treatment, the <i>MEC1</i> P2186A/A2351S double mutant sho...
<p>Mutants of known pathways involved in antioxidant defence and oxidative stress responses were ana...
Data is reported as a ratio of average OD (tx) to average starting OD (t0) in each survival curve (n...